<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A-1
(Mark One)
[X] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
FOR THE FISCAL YEAR ENDED DECEMBER 31, 1999
[ ] Transition report pursuant to Section
13 or 15(d) of the Securities Exchange
Act of 1934 For the Period From _________
to __________.
Commission File Number: 001-14593
THE MIIX GROUP, INCORPORATED
(Exact name of Registrant as specified in its charter)
<TABLE>
<CAPTION>
DELAWARE 22-3586492
<S> <C>
(State or other jurisdiction of incorporation or (I.R.S. employer
organization) identification number)
</TABLE>
TWO PRINCESS ROAD, LAWRENCEVILLE, NEW JERSEY 08648
(Address of principal executive offices and zipcode)
(609) 896-2404
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the
Act: Common Stock, par value $.01 per share
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter periods as the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
YES [X] NO [ ]
Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of Registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [ ]
The aggregate market value on March 22, 2000 of the voting stock held
by non-affiliates of the registrant was $160,652,552.
As of March 22, 2000, the number of outstanding shares of the
Registrant's Common Stock was 14,512,083.
DOCUMENTS INCORPORATED BY REFERENCE IN FORM 10-K
INCORPORATED DOCUMENTS WHERE INCORPORATED
1.Certain portions of the Corporation's Part III - Items 11, 12 and 13
Proxy Statement for the Annual Meeting
of Stockholders to be held
May 5, 2000 ("Proxy Statement").
<PAGE> 2
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) the Securities Exchange Act
of 1934, the Registrant has duly caused this Amended Report to be signed on its
behalf by the undersigned, thereunto duly authorized.
THE MIIX GROUP, INCORPORATED
By: /s/ KENNETH KOREYVA
-----------------------------
Kenneth Koreyva
President and Chief
Executive Officer
April 10, 2000
Pursuant to the requirements of the Securities Exchange Act of 1934, this
Amended Report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated.
<TABLE>
<CAPTION>
Name Title Date
---- ----- ----
<S> <C> <C>
/s/ KENNETH KOREYVA President, Chief Executive
- --------------------
Kenneth Koreyva Officer and Director
(principal executive officer) April 10, 2000
/s/ THOMAS REDMAN Senior Vice President and
- --------------------
Thomas Redman Chief Financial Officer
(principal financial and
accounting officer) April 10, 2000
* Director
- --------------------
Angelo S. Agro, M.D. April 10, 2000
* Director
- --------------------
Harry M. Carnes, M.D. April 10, 2000
* Director
- --------------------
Paul J. Hirsch, M.D. April 10, 2000
* Director
- --------------------
Vincent A. Maressa, Esq. April 10, 2000
* Director
- --------------------
Robert S. Maurer, D.O. April 10, 2000
* Director
- --------------------
A. Richard Miskoff, D.O. April 10, 2000
</TABLE>
2
<PAGE> 3
<TABLE>
<CAPTION>
<S> <C> <C>
* Director
- -----------------------
Charles J. Moloney, M.D. April 10, 2000
* Director
- -----------------------
Eileen Marie Moynihan, M.D. April 10, 2000
* Director
- -----------------------
Carl Restivo, Jr., M.D. April 10, 2000
* Director
- -----------------------
Gabriel F. Sciallis, M.D. April 10, 2000
* Director
- -----------------------
Martin L. Sorger, M.D. April 10, 2000
* Director
- -----------------------
Bessie M. Sullivan, M.D. April 10, 2000
*By: /s/ Kenneth Koreyva
- -----------------------
Attorney-in-Fact
</TABLE>
ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K.
(a)(1) and (2) and (d)
The required schedules as identified on the Index to Financial
Statements on page F-1 of the 10-K are incorporated herein by
reference. All other schedules for which provision is made in the
applicable accounting regulation of the Securities and Exchange
Commission are not required under the related instructions or are
inapplicable and therefore have been omitted.
(a) (3) and (c) The following exhibits are filed herewith unless otherwise
indicated:
Exhibit
Number Description
23.1 Consent of Ernst & Young LLP
3
<PAGE> 1
EXHIBIT 23.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statement (Form
S-8) pertaining to the 1998 Long Term Incentive Equity Plan of The MIIX Group,
Incorporated of our report dated March 22, 2000 with respect to the consolidated
financial statements and schedules of The MIIX Group, Incorporated included in
the Annual Report, as amended (Form 10-K/A-1 filed on April 10, 2000) for the
year ended December 31, 1999.
ERNST & YOUNG LLP
New York, New York
March 30, 2000
